What is the difference between a supraglottic airway (SGA) and a laryngeal mask airway (LMA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Relationship Between Supraglottic Airways and Laryngeal Mask Airways

A laryngeal mask airway (LMA) is a specific type of supraglottic airway device—the LMA is not different from a supraglottic airway, but rather represents the original and most well-known example within this broader device category. 1

Understanding the Terminology

Supraglottic airway (SGA) is the umbrella term for an entire class of airway devices designed to maintain an open airway and facilitate ventilation without requiring visualization of the glottis or passage through the vocal cords. 1

The laryngeal mask airway (LMA) was the pioneering device in this category, first described by Brain in 1983, and it revolutionized airway management in anesthesia. 2 The LMA became so successful that it essentially defined the category, but it is just one specific brand and design among many SGAs now available.

The Full Family of Supraglottic Airways

According to the 2010 American Heart Association guidelines, supraglottic airways studied in cardiac arrest include: 1

  • Laryngeal mask airway (LMA) - the original device and its variants
  • Esophageal-tracheal tube (Combitube)
  • Laryngeal tube (King LT)

Modern practice has expanded to include numerous other SGAs beyond these original devices. 2

Evolution and Generations

The terminology has further evolved to distinguish between:

  • First-generation SGAs: The classic LMA and similar basic designs without additional safety features
  • Second-generation SGAs: Newer devices like the LMA ProSeal, LMA Supreme, i-gel, and others that offer improved oropharyngeal seal pressure and gastric access ports for aspiration risk reduction 3, 4, 5

Clinical Implications

All LMAs are supraglottic airways, but not all supraglottic airways are LMAs. This distinction matters because:

  • Different SGAs have varying performance characteristics for oropharyngeal leak pressure, insertion success rates, and complication profiles 6, 7
  • The 2022 ASA Practice Guidelines recognize multiple SGA options as acceptable alternatives to endotracheal intubation and bag-mask ventilation 8
  • Device selection should be based on specific clinical needs, with second-generation devices preferred when aspiration risk or positive pressure ventilation requirements are concerns 3, 9

Common pitfall: Clinicians sometimes use "LMA" generically to refer to any supraglottic airway, but this is imprecise. The LMA is a specific brand (originally manufactured by Teleflex), while many other manufacturers produce different supraglottic airway designs with distinct features and performance characteristics.

Related Questions

What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
1. What is the major health problem resulting from a pulse deficit? (A) Bradycardia (B) Activity intolerance (C) Decreased cardiac output (D) Impaired tissue perfusion. 2. What should the nurse do when a pulse deficit is suspected? (A) Measure the radial pulse for one minute, then measure the apical pulse for one minute (B) Measure the radial pulse for 30 seconds, then measure the apical pulse for 30 seconds (C) Measure the radial pulse for one minute, wait five minutes, then measure the apical pulse for one minute (D) Ask another health‑care provider to count the radial pulse while the nurse counts the apical pulse. 3. After identifying a pulse deficit, which action should the nurse perform? (A) Reassess the apical‑radial pulse in five minutes (B) Assess the patient for signs of decreased cardiac output (C) Notify the primary health‑care provider of the pulse deficit (D) Initiate interventions directed toward managing the patient’s symptoms. 4. A patient has oral temperature 36.8 °C, radial pulse 112 weak and thready, apical pulse 117 regular, respirations 24 regular, blood pressure 104/56 right arm, 102/50 left arm; what is the pulse deficit? (A) 2 (B) 5 (C) 6 (D) 48. 5. Which of the following is an early manifestation of decreased cardiac output? (A) Fatigue (B) Substernal pain (C) Nail‑bed cyanosis (D) Shortness of breath.
In a 24-year-old woman who experiences severe nausea, shakiness, and dizziness lasting about 30 minutes after sexual intercourse, what are the possible differential diagnoses?
How should a 2-year-old child presenting with a dry cough and wheezing be managed?
Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
In acquired hemophilia A, when should emicizumab (Hemlibra) be used, what dosing regimen is recommended, and what safety precautions and monitoring are required?
How should levetiracetam be initiated and managed for a patient who has a seizure after stroke?
How do I calculate minute ventilation in pediatric patients?
What are the MAC (minimum alveolar concentration) values for sevoflurane, isoflurane, and desflurane?
What are the significant differences between the two lower limbs in deep‑vein thrombosis (DVT)?
Can lamotrigine be prescribed to a patient with mast cell syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.